STAT 80.8%
Halfway into the year, biotech is booming
By Adam Feuerstein - 7/2/2026, 10:30 AM - 67 words
Faulty reasoning signals
- Confirmation Bias - 28.4% (19 hits)
- Anchoring Bias - 29.9% (20 hits)
- Availability Heuristic - 11.9% (8 hits)
- Representativeness Heuristic - 0%
- Hindsight Bias - 0%
- Overconfidence Bias - 0%
- Framing Effect - 38.8% (26 hits)
- Loss Aversion - 0%
- Status Quo Bias - 29.9% (20 hits)
- Sunk Cost Effect - 0%
- Optimism Bias - 10.4% (7 hits)
- Pessimism Bias - 0%
Article text
Halfway into the year, biotech is booming
We’ve reached the midpoint of the year and, wow, biotech has gone nuts.
The sector’s performance in June was especially bonkers.
The XBI, biotech’s most-watched stock index, gained 19% over the past month and is up 30% for the year.
At 158, the XBI is trading at a five-year high and approaching its peak of $175 set in February 2021.